| Angelita Siojo-allen, OTR L | |
|
50 W 3rd St, Sheridan, WY 82801-3606 | |
| (307) 672-2092 | |
| (307) 673-1969 |
| Full Name | Angelita Siojo-allen |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 50 W 3rd St, Sheridan, Wyoming |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750396545 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | OTR287 (Wyoming) | Primary |
| Provider Name | Sherwood Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1346255130 PECOS PAC ID: 8426950767 Enrollment ID: O20040126000655 |
News Archive
Data from the 48-week ART trial, presented today at the Digestive Disease Week meeting, showed that remission and response rates were 37.2% and 53.2% respectively at week 12, in patients with moderate-to-severe, steroid-dependent active ulcerative colitis (UC) with insufficient response or intolerance to immunosuppressants and / or biologics when treated with between five and eight sessions with Adacolumn.
MAXIMUS, Inc., a leading provider of government services worldwide, and Connecture, the leader in Web-based marketplaces and administration solutions for health insurance distribution, announced today that the two companies have entered into a strategic alliance.
The Hill's Healthwatch Blog: "Senate Democrats say an error in the food-safety bill passed Tuesday can be resolved in time to send the legislation to President Obama by the end of the year. Two senior leadership aides confirmed that the bill the Senate approved, 73-25, inadvertently contained tax provisions that, under the Constitution, must originate in the House of Representatives. That means the bill must be passed a second time by the Senate, giving critics such as Sen. Tom Coburn (R-Okla.) another chance to block it" (Rushing and Lillis, 12/1).
Femta Pharmaceuticals announced today that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate a clinical development program for FM101, a high-affinity, humanized monoclonal antibody against Interleukin-6 (IL-6), in patients with rheumatoid arthritis (RA).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angelita Siojo-allen, OTR L 50 W 3rd St, Sheridan, WY 82801-3606 Ph: (307) 672-2092 | Angelita Siojo-allen, OTR L 50 W 3rd St, Sheridan, WY 82801-3606 Ph: (307) 672-2092 |
News Archive
Data from the 48-week ART trial, presented today at the Digestive Disease Week meeting, showed that remission and response rates were 37.2% and 53.2% respectively at week 12, in patients with moderate-to-severe, steroid-dependent active ulcerative colitis (UC) with insufficient response or intolerance to immunosuppressants and / or biologics when treated with between five and eight sessions with Adacolumn.
MAXIMUS, Inc., a leading provider of government services worldwide, and Connecture, the leader in Web-based marketplaces and administration solutions for health insurance distribution, announced today that the two companies have entered into a strategic alliance.
The Hill's Healthwatch Blog: "Senate Democrats say an error in the food-safety bill passed Tuesday can be resolved in time to send the legislation to President Obama by the end of the year. Two senior leadership aides confirmed that the bill the Senate approved, 73-25, inadvertently contained tax provisions that, under the Constitution, must originate in the House of Representatives. That means the bill must be passed a second time by the Senate, giving critics such as Sen. Tom Coburn (R-Okla.) another chance to block it" (Rushing and Lillis, 12/1).
Femta Pharmaceuticals announced today that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) to initiate a clinical development program for FM101, a high-affinity, humanized monoclonal antibody against Interleukin-6 (IL-6), in patients with rheumatoid arthritis (RA).
› Verified 8 days ago
Mrs. Kaitlin Jean Wallace, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 918 W Brundage Ln, Sheridan, WY 82801 Phone: 307-673-4420 | |
Ashton Hudspeth-miller, Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 50 W 3rd St, Sheridan, WY 82801 Phone: 307-672-2092 Fax: 307-673-1969 | |
Alexis Leigh Prosinski, OTR/L Occupational Therapist Medicare: Medicare Enrolled Practice Location: 352 Whitney Ln, Sheridan, WY 82801 Phone: 307-672-5000 | |
Ms. Connie Allmaras, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1898 Fort Road, Vamc, Sheridan, WY 82801 Phone: 307-672-3473 Fax: 307-672-1958 | |
Ms. Clella C Collier, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1898 Fort Rd, Sheridan, WY 82801 Phone: 307-672-3473 Fax: 307-672-1941 | |
Mrs. Ginette Cecile Aasby, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 49 Valley View Dr, Sheridan, WY 82801 Phone: 417-459-8735 | |
Michelle Anne Eman, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 918 W Brundage Ln, Sheridan, WY 82801 Phone: 307-673-4420 |